Skip to content
value.today

Centerline Biomedical, Inc.

Total raised
$72 M
4 rounds on record
Latest round
$11 M
Apr 2025
First round on record
Aug 2015
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Centerline Biomedical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2025$11 MNo. 4$10 to $50 million

Centerline Biomedical, Inc.: Raise no. 4, Apr 2025

Investors in this round

8 investors had bought by the notice of Apr 25, 2025: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $15 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gulam Khan · Executive Officer, Director
  • Indrani Egleston · Executive Officer
  • Arnaud Marie · Director
  • Michael Whitman · Director
  • Mitch Wolf · Director
  • Todd Schwarzinger · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gulam Khan, Ceo. Source: SEC Form D, newest notice filed Apr 25, 2025. Read the notice at the SEC.

equity, debt, optionsSEC
Feb 2022$35 MNo. 3$10 to $50 million

Centerline Biomedical, Inc.: Raise no. 3, Feb 2022

Investors in this round

22 investors had bought by the notice of Nov 3, 2023: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $35 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gulam Khan · Executive Officer
  • Phil Rackliffe · Executive Officer, Director
  • Vikash K. Goel · Executive Officer
  • Vinod K. Goel · Executive Officer
  • Akhil Saklecha · Director
  • Mitch Wolf · Director
  • Todd Schwarzinger · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gulam Khan, Ceo. Source: SEC Form D, newest notice filed Nov 3, 2023. Read the notice at the SEC.

equitySEC
Aug 2019$13 MNo. 2$10 to $50 million

Centerline Biomedical, Inc.: Raise no. 2, Aug 2019

Investors in this round

106 investors had bought by the notice of Nov 3, 2023: 106 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$846,649
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gulam Khan · Executive Officer
  • Phil N. Rackliffe · Executive Officer, Director
  • Vikash N. Goel · Executive Officer
  • Vinod K. Goel · Executive Officer, Director
  • Jai N. Gupta · Director
  • Jim Zalar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Paulson Investment Company, LLC (CRD 5670) · Portland, OregonSold in all US states

Remarks in the notice

  • On fees: “Commission also included common stock warrant to purchase 465,512 shares.”

Signed by Gulam Khan, Ceo. Source: SEC Form D, newest notice filed Nov 3, 2023. Read the notice at the SEC.

equitySEC
Aug 2015$14 MNo. 1$10 to $50 million

Centerline Biomedical, Inc.: Raise no. 1, Aug 2015

Investors in this round

65 investors had bought by the notice of Nov 3, 2023: 65 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gulam Khan · Executive Officer
  • Jai N. Gupta · Executive Officer, Director
  • Vikash K. Goel · Executive Officer
  • Vinod K. Goel · Executive Officer, Director
  • Jim N. Zalar · Director
  • Karen Shanahan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gulam Khan, Ceo. Source: SEC Form D, newest notice filed Nov 3, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Centerline Biomedical, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2025).

    SEC Form D · Apr 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2025

That is all the official record says: Centerline Biomedical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Centerline Biomedical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 106 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Centerline Biomedical, Inc.
NameRoleNamed in
Gulam KhanExecutive officerApr 2025
Indrani EglestonExecutive officerApr 2025
Jai N. GuptaExecutive officerNov 2023
Phil N. RackliffeExecutive officerNov 2023
Phil RackliffeExecutive officerNov 2023
Vikash K. GoelExecutive officerNov 2023
Vikash N. GoelExecutive officerNov 2023
Vinod K. GoelExecutive officerNov 2023
Arnaud MarieDirectorApr 2025
Gulam KhanDirectorApr 2025
Michael WhitmanDirectorApr 2025
Mitch WolfDirectorApr 2025
Todd SchwarzingerDirectorApr 2025
Akhil SaklechaDirectorNov 2023
Jai N. GuptaDirectorNov 2023
Jim N. ZalarDirectorNov 2023
Jim ZalarDirectorNov 2023
Karen ShanahanDirectorNov 2023
Phil N. RackliffeDirectorNov 2023
Phil RackliffeDirectorNov 2023
Vinod K. GoelDirectorNov 2023